Virtual Reality in End Stage Kidney Disease (NCT06356168)
Social Virtual Reality to Alleviate Loneliness and Symptoms for Individuals Receiving Hemodialysis
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
Who can join: Review the eligibility criteria below.
Location: University of Pennsylvania — Philadelphia, Pennsylvania
🧪 Interventions in This Study
- Social Virtual Reality (BEHAVIORAL)
- Individual Virtual Reality (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Pennsylvania — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (215) 746-8819
Email: matura@nursing.upenn.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in End Stage Kidney Disease
- Immunological Tolerance in Patients With Mismatched Kidney Transplants — Los Angeles, California
- Pain Reduction Using NEurostimulation Study — New York, New York
- Virtual Reality in Hemodialysis to Improve Psychological Well-being — Chicago, Illinois
- Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease — New York, New York
- Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants — San Dimas, California
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Decatur, Alabama
Explore by condition: All End Stage Kidney Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.